Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2026-02-24 @ 10:20 PM
Study NCT ID:
NCT01695668
Status:
COMPLETED
Last Update Posted:
2015-09-24
First Post:
2012-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%
Sponsor:
University of Michigan
Organization: